Novavax Expects COVID Vaccine Targeting Omicron in Fourth Quarter
Novavax Inc said it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development of shots to protect against the BA.4 and BA.5 subvariants.
Reuters Health Information
source https://www.medscape.com/viewarticle/976700?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/976700?src=rss
Comments
Post a Comment